Expression of vascular endothelial growth factor and caspase-3 in mucinous breast carcinoma and infiltrating ductal carcinoma-not otherwise specified, and the correlation with disease-free survival

Wang,Qiuli; Sun,Lisha; Yan,Jici; Wang,Shuo; Zhang,Juncheng; Zheng,Xinyu

doi:10.3892/ol.2017.6744

Expression of vascular endothelial growth factor and caspase-3 in mucinous breast carcinoma and infiltrating ductal carcinoma-not otherwise specified, and the correlation with disease-free survival

Authors:
- Qiuli Wang
- Lisha Sun
- Jici Yan
- Shuo Wang
- Juncheng Zhang
- Xinyu Zheng
View Affiliations

Affiliations: Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: August 10, 2017 https://doi.org/10.3892/ol.2017.6744
Pages: 4890-4896

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mucinous breast carcinoma (MBC) is a rare type of breast cancer, but it has been infrequently studied due to its associated good prognosis. Vascular endothelial growth factor (VEGF) and caspase-3 have been identified to be prognostic factors of infiltrating ductal carcinoma‑not otherwise specified (IDC‑NOS), but their expression in MBC has not been reported. In the present study, the expression of caspase‑3 and VEGF in MBC and IDC‑NOS were assessed by immunohistochemistry. Scoring was conducted based on staining intensity and percentage of positive cells. Based on the scores of caspase‑3 and VEGF expression, all patient samples were divided into two groups: Low expression (score of 0‑5) or high expression (score of 6‑12). In total, 42.59% of MBC patients exhibited a high VEGF score compared with 61.67% of the IDC‑NOS group (P<0.05). Furthermore, 57.41% of MBC patients exhibited high caspase‑3 expression compared with only 33.33% of IDC‑NOS patients (P<0.05). VEGF expression in MBC was associated with age, nodal status and tumor‑node‑metastasis (TNM) stage. Cox univariate analysis showed that higher VEGF expression, positive nodal status and higher TNM stage were associated with shorter disease‑free survival (DFS). The Kaplan‑Meier method showed that higher VEGF expression in MBC was associated with worse DFS times, while Cox multivariate analysis showed that only TNM stage was significantly associated with DFS. VEGF and caspase‑3 expression varied in the MBC and IDC‑NOS samples, but neither was directly correlated with DFS in the MBC patients.

View Figures

View References

1	Dumitru A, Procop A, Iliesiu A, Tampa M, Mitrache L, Costache M, Sajin M, Lazaroiu A and Cirstoiu M: Mucinous breast cancer: A review study of 5 year experience from a hospital-based series of cases. Maedica (Buchar). 10:14–18. 2015.PubMed/NCBI
2	Ranade A, Batra R, Sandhu G, Chitale RA and Balderacchi J: Clinicopathological evaluation of 100 cases of mucinous carcinoma of breast with emphasis on axillary staging and special reference to a micropapillary pattern. J Clin Pathol. 63:1043–1047. 2010. View Article : Google Scholar : PubMed/NCBI
3	Komaki K, Sakamoto G, Sugano H, Morimoto T and Monden Y: Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer. 61:989–996. 1988. View Article : Google Scholar : PubMed/NCBI
4	Ha KY, Deleon P and Deleon W: Invasive mucinous carcinoma of the breast. Proc (Bayl Univ Med Cent). 26:295–297. 2013.PubMed/NCBI
5	Le Querrec A, Duval D and Tobelem G: Tumour angiogenesis. Baillieres Clin Haematol. 6:711–730. 1993. View Article : Google Scholar : PubMed/NCBI
6	Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature. 407:242–248. 2000. View Article : Google Scholar : PubMed/NCBI
7	Gasparini G: Prognostic value of vascular endothelial growth factor in breast cancer. The oncologist 5 Suppl. 1:37–44. 2000. View Article : Google Scholar
8	Norris HJ and Taylor HB: Prognosis of mucinous (Gelatinous) carcinoma of the breast. Cancer. 18:879–885. 1965. View Article : Google Scholar : PubMed/NCBI
9	Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E and Yonezawa S: Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: Comparison with invasive ductal carcinoma. Histopathology. 42:26–36. 2003. View Article : Google Scholar : PubMed/NCBI
10	Ahmed A: The myoepithelium in human breast carcinoma. J Pathol. 113:129–135. 1974. View Article : Google Scholar : PubMed/NCBI
11	Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons DL, Akbar AN, Lord JM and Salmon M: RGD peptides induce apoptosis by direct caspase-3 activation. Nature. 397:534–539. 1999. View Article : Google Scholar : PubMed/NCBI
12	Jänicke RU, Sprengart ML, Wati MR and Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 273:9357–9360. 1998. View Article : Google Scholar : PubMed/NCBI
13	Mazumder S, Plesca D and Almasan A: Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 414:13–21. 2008.PubMed/NCBI
14	Frank GA, Danilova NV, Andreeva IuIu and Nefedova NA: WHO classification of tumors of the breast, 2012. Arkh Patol. 75:53–63. 2013.(In Russian). PubMed/NCBI
15	Edge SB, Byrd DR and Compton CC: AJCC Cancer Staging Manual. 7th. Springer; New York, NY: 2010
16	Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S and Hirakawa K: Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma. Springerplus. 2:4812013. View Article : Google Scholar : PubMed/NCBI
17	Zekioglu O, Erhan Y, Ciris M and Bayramoglu H: Neuroendocrine differentiated carcinomas of the breast: A distinct entity. Breast. 12:251–257. 2003. View Article : Google Scholar : PubMed/NCBI
18	Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ and Yang JH: Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: Clinicopathologic characteristics and prognosis. J Breast Cancer. 14:308–313. 2011. View Article : Google Scholar : PubMed/NCBI
19	Park S, Koo J, Kim JH, Yang WI, Park BW and Lee KS: Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: Comparison with invasive ductal carcinoma-not otherwise specified. J Korean Med Sci. 25:361–368. 2010. View Article : Google Scholar : PubMed/NCBI
20	Tseng HS, Lin C, Chan SE, Chien SY, Kuo SJ, Chen ST, Chang TW and Chen DR: Pure mucinous carcinoma of the breast: Clinicopathologic characteristics and long-term outcome among Taiwanese women. World J Surg Oncol. 11:1392013. View Article : Google Scholar : PubMed/NCBI
21	Jao W, Lao IO, Chowdhury LN and Gould VE: Ultrastructural aspects of mucinous (colloid) breast carcinoma. Diagn Gynecol Obstet. 2:83–92. 1980.PubMed/NCBI
22	Rosen LS: VEGF-targeted therapy: Therapeutic potential and recent advances. Oncologist. 10:382–391. 2005. View Article : Google Scholar : PubMed/NCBI
23	Ng IO, Poon RT, Lee JM, Fan ST, Ng M and Tso WK: Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol. 116:838–845. 2001. View Article : Google Scholar : PubMed/NCBI
24	Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K and Sasaki T: Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 5:1823–1829. 1999.PubMed/NCBI
25	Hein A, Lambrechts D, von Minckwitz G, Häberle L, Eidtmann H, Tesch H, Untch M, Hilfrich J, Schem C, Rezai M, et al: Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study. Int J Cancer. 137:2981–2988. 2015. View Article : Google Scholar : PubMed/NCBI
26	McIlwain DR, Berger T and Mak TW: Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 5:a0086562013. View Article : Google Scholar : PubMed/NCBI
27	Fuchs Y and Steller H: Programmed cell death in animal development and disease. Cell. 147:742–758. 2011. View Article : Google Scholar : PubMed/NCBI
28	Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O'Sullivan B, He Z, Peng Y, Tan AC, et al: Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 17:860–866. 2011. View Article : Google Scholar : PubMed/NCBI
29	Kontzoglou K, Palla V, Karaolanis G, Karaiskos I, Alexiou I, Pateras I, Konstantoudakis K and Stamatakos M: Correlation between Ki67 and breast cancer prognosis. Oncology. 84:219–225. 2013. View Article : Google Scholar : PubMed/NCBI